A 78-year-old man was referred to our department with a one-week history of dyspnea and coughing. A chest X-ray showed massive left pleural effusion. Computed tomography revealed diffuse irregular thickening of the left pleura similar to malignant mesothelioma and multiple nodules in both lungs. The patient died of respiratory failure nine days after hospitalization. An autopsy revealed metastasis to the pleura and lungs from urothelial carcinoma of the left kidney.
Introduction
Pseudomesotheliomatous carcinoma is a malignant tumor that extends along the pleura similar to malignant mesothelioma. Almost all cases originate from lung cancer, particularly adenocarcinoma. However, pseudomesotheliomatous progression rarely occurs in pleural metastasis from breast, ovarian, gastrointestinal, renal or urinary tract cancer (1, 2) . We herein report the case of a Japanese man who died of pseudomesotheliomatous carcinoma from renal pelvic cancer.
Case Report
A 78-year-old man was admitted to our department for an evaluation and treatment of massive left pleural effusion on a chest X-ray. He had a one-week history of dyspnea, coughing and loss of appetite. He had no previous asbestos exposure or smoking history. Regarding the patient's blood count and blood chemistry, the white blood cell count was 15,300/μL, the C-reactive protein level was 20.4 mg/dL, the creatinine level was 1.75 mg/dL, the squamousceHcarcbomarelatedantigen (SCC) level was 250 ng/mL and the cytokeratin 19 fragment (CYFRA) level was 1.7 ng/mL. The pleural effusion was exudative, and the level of hyaluronic acid was 40,100 ng/mL. Cytology of the fluid revealed a class III status. Computed tomography (CT) demonstrated diffuse thickening of the left pleura, multiple areas of nodular density in both lung fields and an irregular mass measuring 6.0×5.0 cm in the left kidney (Fig. 1) . A urinalysis showed no proteinuria or hematuria. A thoracoscopic pleural biopsy was scheduled; however, the patient's condition rapidly deteriorated. On the ninth day after admission, he died of respiratory and cardiovascular failure and disseminated intravascular coagulation.
On autopsy, a 6.5-cm sized, whitish, irregular solid tumor was detected on the upper middle part of the left kidney (Fig. 2) . The left pleura was circumferentially thickened along with the tumor, a part of which had infiltrated the lung parenchyma. Histopathology showed poorly differentiated transitional cell carcinoma and comorbid squamous cell carcinoma in both the renal pelvis and lung lesions (Fig. 3) . Therefore, a diagnosis of urothelial carcinoma of the left kidney (grade 3, stage IV) with metastasis to the left pleura and lung was established. 
Discussion
A diffuse growth pattern of a pleural neoplasm radiologically mimicking malignant mesothelioma, so-called 'pseudomesotheliomatous carcinoma,' was first reported by Harwood et al. (3) Attanoos reported the most common primary site for pseudomesotheliomatous pleural metastasis to be peripheral lung cancer (88%). Other primary sites include transitional cell carcinoma of the bladder (4%), renal cell carcinoma (2%), ductal pancreatic adenocarcinoma (2%), prostatic adenocarcinoma (2%) and so on (1); such tumors are associated with a poor prognosis (1). In patients with pseudomesotheliomatous carcinomas, diffuse thickening of the pleura, pleural effusion and nodules in the lungs are common features, although pleural plaque is less common than in patients with malignant mesothelioma (1). Differentiating between pseudomesotheliomatous carcinoma and malignant mesothelioma based on appearance only is sometimes difficult. Therefore, the combination of imaging and pathological findings is essential for diagnosis. Immunohistochemistry is an effective method, and the level of carcinoembryonic antigen has been found to be the most specific marker for adenocarcinoma (1) . The thyroid transcription factor-1 level has also been shown to be a useful marker for primary lung adenocarcinoma (4) . On the other hand, the calretinin level has been demonstrated to be a highly sensitive and specific marker for mesothelioma (1) .
Transitional cell carcinoma of the renal pelvis accounts for only 5-6% of all urothelial tumors. Distant metastasis to the lungs, liver and colon is frequently recognized (5), although metastasis to the cardiac chamber (6, 7), cerebrum (8) and skin (9) rarely occurs. However, there are no reported cases of pseudomesotheliomatous carcinoma originating from transitional cell carcinoma of the renal pelvis. In the present case, we suppose that the cancer metastasized hematogenously, as the autopsy revealed invasion of the cancer to the renal vein without lymph node metastasis in either the abdominal or thoracic cavity.
In conclusion, in the present case, transitional cell carcinoma of the renal pelvis diffusely metastasized to the pleura, which manifested with mesothelioma-like findings. Although rare, renal pelvic cancer should be taken into account as a primary site of pseudomesotheliomatous carcinoma.
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